-
公开(公告)号:US20210396754A1
公开(公告)日:2021-12-23
申请号:US17279534
申请日:2019-10-10
申请人: Nantomics, LLC
IPC分类号: G01N33/569 , A61K39/00 , A61K38/17 , A61K35/17 , A61K39/395 , C12Q1/6886 , G01N33/574
摘要: Effectiveness of a neoepitope-based immunotherapeutic composition against a tumor can be increased by predicting the surface presentation of the neoepitope bound to the HLA molecule of the tumor cell. Surface presentation levels of neoepitopes can be predicted by identifying any changes in omics data of the tumor cell that may affect the expression or surface trafficking of the HLA molecule and that may affect binding affinities of neoepitopes to the HLA molecule.
-
公开(公告)号:US20190272892A1
公开(公告)日:2019-09-05
申请号:US16420040
申请日:2019-05-22
申请人: NantOmics, LLC
摘要: Complex genotypes, especially multiple single nucleotide variances, that may differentially distributed among alleles can be efficiently mapped in each allele of the gene using next generation sequencing of RNA transcripts from the alleles and the allele fraction information of RNA transcripts. Such reconstructed single nucleotide variances among alleles can be associated with the expected effectiveness of the cancer therapy to update or generate the patient's record or adjust the dose and schedule of the cancer therapy to reduce the undesirable effect of the cancer therapy.
-
公开(公告)号:US20180357368A1
公开(公告)日:2018-12-13
申请号:US16003028
申请日:2018-06-07
申请人: NantOmics, LLC
IPC分类号: G06F19/22
CPC分类号: G06F19/22
摘要: Complex genotypes, especially multiple single nucleotide variances, that may differentially distributed among alleles can be efficiently mapped in each allele of the gene using next generation sequencing of RNA transcripts from the alleles and the allele fraction information of RNA transcripts. Such reconstructed single nucleotide variances among alleles can be associated with the expected effectiveness of the cancer therapy to update or generate the patient's record or adjust the dose and schedule of the cancer therapy to reduce the undesirable effect of the cancer therapy.
-
公开(公告)号:US20180237949A1
公开(公告)日:2018-08-23
申请号:US15755095
申请日:2016-08-25
申请人: Nantomics, LLC
发明人: John Zachary Sanborn
摘要: Systems and methods for in silico prediction of HLA type of a patient are presented in which patient sequence reads and a reference sequence with known and distinct HLA alleles are used in a de Bruijn graph. A composite match score is then used to rank HLA alleles, thus providing a first HLA type. A second HLA type is identified by re-ranking using an adjusted composite match score.
-
公开(公告)号:US20170032103A1
公开(公告)日:2017-02-02
申请号:US15291516
申请日:2016-10-12
申请人: NantOmics, LLC
CPC分类号: G16C20/60 , A61K39/00 , A61K39/0011 , C12Q1/708 , C12Q2600/106 , C12Q2600/156 , G16B20/30 , G16B35/00 , G16H10/40 , G16H20/40
摘要: Contemplated antiviral/cancer treatments comprise analysis of neoepitopes from viral DNA that has integrated into the host genome, and design of immunotherapeutic agents against such neoepitopes.
摘要翻译: 沉思的抗病毒/癌症治疗包括从整合到宿主基因组中的病毒DNA的新表皮分析,以及针对这种新表皮的免疫治疗剂的设计。
-
公开(公告)号:US20160070855A1
公开(公告)日:2016-03-10
申请号:US14846290
申请日:2015-09-04
发明人: John Zachary Sanborn , Charles Joseph Benz , Stephen Charles Benz , Shahrooz Rabizadeh , Patrick Soon-Shiong
IPC分类号: G06F19/22
摘要: Systems and methods for genomic analysis are contemplated in which idiosyncratic markers or marker constellations are employed to characterize and compare genomic sequences. In especially preferred aspects, the idiosyncratic markers are predetermined SNPs and a marker profile is used in a sample record to so allow cross reference to other marker profiles of other sequences.
摘要翻译: 考虑用于基因组分析的系统和方法,其中使用特异性标记或标记星座来表征和比较基因组序列。 在特别优选的方面,特异性标记是预定的SNP,并且在样品记录中使用标记谱,以允许与其他序列的其他标记谱的交叉参考。
-
公开(公告)号:US20240321392A1
公开(公告)日:2024-09-26
申请号:US18740319
申请日:2024-06-11
申请人: Nantomics LLC
IPC分类号: G16B20/30 , A61K39/00 , C12Q1/70 , G16B35/00 , G16C20/60 , G16H10/40 , G16H20/10 , G16H20/40 , G16H70/60
CPC分类号: G16B20/30 , A61K39/0011 , C12Q1/708 , G16B35/00 , G16C20/60 , G16H10/40 , G16H20/10 , G16H20/40 , G16H70/60 , A61K39/00 , C12Q2600/106 , C12Q2600/156
摘要: Contemplated antiviral/cancer treatments comprise analysis of neoepitopes from viral DNA that has integrated into the host genome, and design of immunotherapeutic agents against such neoepitopes.
-
公开(公告)号:US20240079089A1
公开(公告)日:2024-03-07
申请号:US18506554
申请日:2023-11-10
申请人: Nantomics LLC
IPC分类号: G16B25/10 , C12Q1/6827 , C12Q1/6869 , G16B20/00 , G16B20/20 , G16B30/10 , G16B40/00 , G16H50/20 , G16H50/30
CPC分类号: G16B25/10 , C12Q1/6827 , C12Q1/6869 , G16B20/00 , G16B20/20 , G16B30/10 , G16B40/00 , G16H50/20 , G16H50/30 , G01N2570/00 , Y02A90/10
摘要: Systems and methods for prediction of the treatment outcome for immune therapy are presented in which omics data of a patient tumor sample are used. Most typically, the omics data are processed to identify mutational signatures (especially APOBEC/POLE signatures), immune checkpoint expression, and MSI status as leading indicators to predict the treatment outcome for immune therapy. Such prediction advantageously integrates various parameters that would otherwise, when individually considered, skew prediction outcome.
-
公开(公告)号:US20220296642A1
公开(公告)日:2022-09-22
申请号:US17294891
申请日:2019-12-03
申请人: NANTOMICS, LLC
IPC分类号: A61K35/17 , C12N5/0783 , A61P35/00
摘要: Therapeutic T cells can be prepared from a population of TILs (tumor infiltrating lymphocytes) using tumor and patient-specific neoantigens expressed in antigen presenting cells to select for tumor reactive T cells. Selected tumor reactive T cells are then expanded and administered to the patient.
-
公开(公告)号:US20210313012A1
公开(公告)日:2021-10-07
申请号:US16972520
申请日:2019-06-06
申请人: Nantomics, LLC
摘要: Methods for analyzing omics data and using the omics data to determine genetic distances and/or difference scores among a plurality of biological samples to so further determine the homogeneity of a group having a plurality of biological samples and/or exclude an individual biological sample from a group of biological samples as an outlier are presented. In preferred methods, a plurality of local differential string sets among the plurality of sequence strings is generated using a plurality of local alignments. The local different string is an indicative of genetic difference between one sequence string and one of the rests of the sequence strings among the plurality of sequence strings. From the plurality of local differential string sets, a plurality of difference scores among the plurality of sequence strings can be determined.
-
-
-
-
-
-
-
-
-